These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 231595)

  • 1. Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glioma.
    Costanza M; Buechler M; Munzenreider J; Emami B; Mukherji B; Shucart W; Scott M; Nathanson L; Rudders R; Stein B; Post K; Piro A
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1589-92. PubMed ID: 231595
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system tumors of childhood treated with CCNU, vincristine, and radiation.
    Ward HW
    Med Pediatr Oncol; 1978; 4(4):315-20. PubMed ID: 723796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled study of CCNU and radiation therapy in malignant astrocytoma.
    Reagan TJ; Bisel HF; Childs DS; Layton DD; Rhoton AL; Taylor WF
    J Neurosurg; 1976 Feb; 44(2):186-90. PubMed ID: 173814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors--a preliminary report.
    Hildebrand J; Brihaye J; Wagenknecht L; Michel J; Kenis Y
    Eur J Cancer (1965); 1973 Sep; 9(9):627-34. PubMed ID: 4803230
    [No Abstract]   [Full Text] [Related]  

  • 6. CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme.
    Cianfriglia F; Pompili A; Riccio A; Grassi A
    Cancer; 1980 Mar; 45(6):1289-99. PubMed ID: 6244079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.
    Crafts DC; Levin VA; Edwards MS; Pischer TL; Wilson CB
    J Neurosurg; 1978 Oct; 49(4):589-92. PubMed ID: 690688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of bone marrow toxicity of VM-26-CCNU combination by bleomycin.
    Hildebrand J; Gangji D; Nouwynck C; Machin D
    Cancer Treat Rep; 1977 Dec; 61(9):1695-8. PubMed ID: 74284
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.
    Avellanosa AM; West CR; Tsukada Y; Higby DJ; Bakshi S; Reese PA; Jennings E
    Cancer; 1979 Sep; 44(3):839-46. PubMed ID: 225004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas.
    Seiler RW; Greiner RH; Zimmerman A; Markwalder H
    J Neurosurg; 1978 Jun; 48(6):861-5. PubMed ID: 77898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Letter: Chemotherapy of operated malignant brain gliomas using a combination of VM 26 and CCNU].
    Paillas JE; Pellet W; Pollet JF; D'Estienne d'Orves JF
    Nouv Presse Med; 1976 Feb; 5(7):433-4. PubMed ID: 768919
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
    J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R; Bernheim J; Cumps E; Buyse M; Kenis Y
    Cancer Treat Rep; 1981; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract]   [Full Text] [Related]  

  • 14. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
    Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P; Barrelet L; Chapuis B; Garcia B
    Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
    [No Abstract]   [Full Text] [Related]  

  • 17. PCV chemotherapy for recurrent glioblastoma.
    Schmidt F; Fischer J; Herrlinger U; Dietz K; Dichgans J; Weller M
    Neurology; 2006 Feb; 66(4):587-9. PubMed ID: 16505319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors of children.
    Seiler RW
    Helv Paediatr Acta; 1980 Mar; 35(1):51-6. PubMed ID: 7410103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine.
    Heiss WD; Turnheim M; Mamoli B
    Eur J Cancer (1965); 1978 Nov; 14(11):1191-202. PubMed ID: 216554
    [No Abstract]   [Full Text] [Related]  

  • 20. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
    Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB
    Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.